173 related articles for article (PubMed ID: 25608278)
1. 3D-Printed Drug/Cell Carrier Enabling Effective Release of Cyclosporin A for Xenogeneic Cell-Based Therapy.
Song TH; Jang J; Choi YJ; Shim JH; Cho DW
Cell Transplant; 2015; 24(12):2513-25. PubMed ID: 25608278
[TBL] [Abstract][Full Text] [Related]
2. Cyclosporine A-loaded and stem cell-seeded electrospun nanofibers for cell-based therapy and local immunosuppression.
Holan V; Chudickova M; Trosan P; Svobodova E; Krulova M; Kubinova S; Sykova E; Sirc J; Michalek J; Juklickova M; Munzarova M; Zajicova A
J Control Release; 2011 Dec; 156(3):406-12. PubMed ID: 21802460
[TBL] [Abstract][Full Text] [Related]
3. Circumventing the blood-brain barrier: Local delivery of cyclosporin A stimulates stem cells in stroke-injured rat brain.
Tuladhar A; Morshead CM; Shoichet MS
J Control Release; 2015 Oct; 215():1-11. PubMed ID: 26226344
[TBL] [Abstract][Full Text] [Related]
4. A hydrogel composite system for sustained epi-cortical delivery of Cyclosporin A to the brain for treatment of stroke.
Caicco MJ; Cooke MJ; Wang Y; Tuladhar A; Morshead CM; Shoichet MS
J Control Release; 2013 Mar; 166(3):197-202. PubMed ID: 23306024
[TBL] [Abstract][Full Text] [Related]
5. Preparation and testing of cyclosporine microsphere and solution formulations in the treatment of polyarthritis in rats.
D'Souza M; DeSouza P
Drug Dev Ind Pharm; 1998 Sep; 24(9):841-52. PubMed ID: 9876535
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic and toxicological evaluations of cyclosporine a microspheres as a treatment vehicle for uveitis in rabbits.
He Y; Wang JC; Liu YL; Ma ZZ; Zhu XA; Zhang Q
J Ocul Pharmacol Ther; 2006 Apr; 22(2):121-31. PubMed ID: 16722798
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of subconjunctival cyclosporin-containing microspheres on keratoplasty rejection in the rabbit.
de Rojas Silva MV; Rodríguez-Ares MT; Sánchez-Salorio M; Lamas Díaz MJ; Cuevas Alvarez J; Vila Jato JL; Capeans Tomé C
Graefes Arch Clin Exp Ophthalmol; 1999 Oct; 237(10):840-7. PubMed ID: 10502059
[TBL] [Abstract][Full Text] [Related]
8. Combination of N-(3'4'-dimethoxycinnamoyl) anthranilic acid with cyclosporin A treatment preserves immunosuppressive effect and reduces the side effect of cyclosporin A in rat.
Yong-Gang X; Ming-Zhe W; Jin-Yan Z; Zhi-Hai P; Jun-Ming X
Eur J Pharmacol; 2014 Apr; 728():16-23. PubMed ID: 24530417
[TBL] [Abstract][Full Text] [Related]
9. Promoting bioengineered tooth innervation using nanostructured and hybrid scaffolds.
Kuchler-Bopp S; Larrea A; Petry L; Idoux-Gillet Y; Sebastian V; Ferrandon A; Schwinté P; Arruebo M; Benkirane-Jessel N
Acta Biomater; 2017 Mar; 50():493-501. PubMed ID: 28057509
[TBL] [Abstract][Full Text] [Related]
10. Cyclosporine-loaded microspheres for treatment of uveitis: in vitro characterization and in vivo pharmacokinetic study.
He Y; Liu Y; Liu Y; Wang J; Zhang X; Lu W; Ma Z; Zhu X; Zhang Q
Invest Ophthalmol Vis Sci; 2006 Sep; 47(9):3983-8. PubMed ID: 16936114
[TBL] [Abstract][Full Text] [Related]
11. Poly(D,L-lactic-co-glycolic acid) microsphere delivery of adenovirus for vaccination.
Wang D; Molavi O; Lutsiak ME; Elamanchili P; Kwon GS; Samuel J
J Pharm Pharm Sci; 2007; 10(2):217-30. PubMed ID: 17706180
[TBL] [Abstract][Full Text] [Related]
12. [Prolongation of corneal allograft survival in mice with a cyclosporine drug delivery system implant].
Shi W; Xie L; Wang S
Zhonghua Yan Ke Za Zhi; 2002 Aug; 38(8):502-5. PubMed ID: 12410993
[TBL] [Abstract][Full Text] [Related]
13. Cyclosporin a improves pregnancy outcome by promoting functions of trophoblasts and inducing maternal tolerance to the allogeneic fetus in abortion-prone matings in the mouse.
Du MR; Dong L; Zhou WH; Yan FT; Li DJ
Biol Reprod; 2007 May; 76(5):906-14. PubMed ID: 17229932
[TBL] [Abstract][Full Text] [Related]
14. Multi-morphological biodegradable PLGE nanoparticles and their drug release behavior.
Zhang H; Bei J; Wang S
Biomaterials; 2009 Jan; 30(1):100-7. PubMed ID: 18848724
[TBL] [Abstract][Full Text] [Related]
15. Multifunctional hydrogel-based scaffold for improving the functionality of encapsulated therapeutic cells and reducing inflammatory response.
Acarregui A; Herrán E; Igartua M; Blanco FJ; Pedraz JL; Orive G; Hernandez RM
Acta Biomater; 2014 Oct; 10(10):4206-16. PubMed ID: 25010523
[TBL] [Abstract][Full Text] [Related]
16. Protein functionalized tramadol-loaded PLGA nanoparticles: preparation, optimization, stability and pharmacodynamic studies.
Lalani J; Rathi M; Lalan M; Misra A
Drug Dev Ind Pharm; 2013 Jun; 39(6):854-64. PubMed ID: 22799442
[TBL] [Abstract][Full Text] [Related]
17. Feasibility of localized immunosuppression: 2. PLA microspheres for the sustained local delivery of a soft immunosuppressant.
Pinto E; Zhang B; Song S; Bodor N; Buchwald P; Hochhaus G
Pharmazie; 2010 Jun; 65(6):429-35. PubMed ID: 20614691
[TBL] [Abstract][Full Text] [Related]
18. The immunosuppressive activity of polymeric micellar formulation of cyclosporine A: in vitro and in vivo studies.
Hamdy S; Haddadi A; Shayeganpour A; Alshamsan A; Montazeri Aliabadi H; Lavasanifar A
AAPS J; 2011 Jun; 13(2):159-68. PubMed ID: 21336534
[TBL] [Abstract][Full Text] [Related]
19. Controlled release carrier of BSA made by W/O/W emulsion method containing PLGA and hydroxyapatite.
Ho ML; Fu YC; Wang GJ; Chen HT; Chang JK; Tsai TH; Wang CK
J Control Release; 2008 Jun; 128(2):142-8. PubMed ID: 18436324
[TBL] [Abstract][Full Text] [Related]
20. The interactive effect of exercise and immunosuppressant cyclosporin A on immune function in mice.
Ko MH; Chang CK; Wu CL; Hou YC; Hong W; Fang SH
J Sports Sci; 2010 Jul; 28(9):967-73. PubMed ID: 20563916
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
